Latest NCI Inc (NCIT) Headlines
91.4% Return Seen to Date on SmarTrend NCI Call (NCIT)
Comtex SmarTrend(R) - Tue Mar 11, 9:09AM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 4 months, NCI has returned 91.40% as of today's recent price of $11.13.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Computer Sciences Corporation (CSC) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:40AM CST
Computer Sciences Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.
Research and Markets: Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014 Research Report
Business Wire - Fri Feb 28, 5:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/4s4f23/hidradenitis) has announced the addition of the "Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014" report to their offering.
Lubega Predicts Ko Win
by Moses Mugalu - All Africa Global Media - Wed Feb 26, 12:33AM CST
Professional boxer Joseph Lubega has predicted a knockout victory over South African Ryno Liebenberg in their scheduled World Boxing Council International (WBC-I) light heavyweight title contest due this Saturday, March 1 in Johannesburg.
Can NCI (NCIT) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 7:47AM CST
Stock of NCI looks promising, as it is seeing solid activity on the earnings estimate revision front
Ebix Inc. (EBIX) Jumps: Stock Rises 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 8:18AM CST
Ebix Inc. (EBIX) was a big mover last session, as the company saw its shares rise by over 9% on the day.
Nasdaq stocks posting largest volume increases
AP - Tue Feb 18, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Can the Rally in NCI (NCIT) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 18, 6:30AM CST
Can the Rally in NCI (NCIT) Shares Continue?
NCI Has Returned 48.6% Since SmarTrend Recommendation (NCIT)
Comtex SmarTrend(R) - Thu Feb 13, 4:42PM CST
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 3 months, NCI has returned 48.58% as of today's recent price of $8.64.
NCI Reports Fourth Quarter and Fiscal Year 2013 Financial and Operating Results
Business Wire - Wed Feb 12, 3:01PM CST
--EPS of $0.16 exceeds high end of guidance by $0.05;
NCI Awarded $9 Million Contract for the Reserve Component Automation Systems (RCAS) Project Directorate, Alexandria, VA
Business Wire - Mon Feb 10, 7:00AM CST
NCI, Inc. (NASDAQ:NCIT), a leading provider of information technology (IT) and professional services and solutions to U.S. Federal Government agencies, announced today that it was awarded a $9 million contract in support of the Program Executive Office Enterprise Information Systems (PEO EIS) Project Director Reserve Component Automation Systems (RCAS), whose mission includes sustainment of automated information systems that enhance the Army Reserve Component's ability to achieve and sustain critical automation interoperability. The contract will also help to accomplish the directorate's goals of providing the citizen soldiers of our nation with information technology solutions that support unit mobilization planning, training, day-to-day operations, communications, and administration through the use of RCAS. This contract award represents new work for NCI and consists of a three month base period and two additional one-year option periods through 2016.
Shares of NCIT Up 15.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 06, 11:10AM CST
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 3 months, NCI has returned 15.22% as of today's recent price of $6.70.
NCI Shares Up 25.0% Since SmarTrend's Buy Recommendation (NCIT)
Comtex SmarTrend(R) - Thu Jan 23, 9:19AM CST
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 3 months, NCI has returned 25.02% as of today's recent price of $7.27.
NCI, Inc. Schedules Fourth Quarter and Fiscal Year 2013 Conference Call for February 12, 2014
Business Wire - Tue Jan 21, 7:00AM CST
NCI, Inc. (NASDAQ:NCIT) announced today it will issue fourth quarter and fiscal year 2013 financial results after the market closes on Wednesday, February 12, 2014. Management will then discuss the results as well as operating trends and future performance expectations on a conference call beginning at 4:30 p.m. Eastern Time.
NCI Up 21.1% Since SmarTrend Uptrend Call (NCIT)
Comtex SmarTrend(R) - Wed Jan 15, 5:04PM CST
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 2 months, NCI has returned 21.07% as of today's recent price of $7.04.
91.4% Return Seen to Date on SmarTrend NCI Call (NCIT)
Comtex SmarTrend(R) - Tue Mar 11, 9:09AM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 4 months, NCI has returned 91.40% as of today's recent price of $11.13.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Computer Sciences Corporation (CSC) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:40AM CST
Computer Sciences Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.
Research and Markets: Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014 Research Report
Business Wire - Fri Feb 28, 5:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/4s4f23/hidradenitis) has announced the addition of the "Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014" report to their offering.
Lubega Predicts Ko Win
by Moses Mugalu - All Africa Global Media - Wed Feb 26, 12:33AM CST
Professional boxer Joseph Lubega has predicted a knockout victory over South African Ryno Liebenberg in their scheduled World Boxing Council International (WBC-I) light heavyweight title contest due this Saturday, March 1 in Johannesburg.
Can NCI (NCIT) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 7:47AM CST
Stock of NCI looks promising, as it is seeing solid activity on the earnings estimate revision front
Ebix Inc. (EBIX) Jumps: Stock Rises 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 8:18AM CST
Ebix Inc. (EBIX) was a big mover last session, as the company saw its shares rise by over 9% on the day.
Nasdaq stocks posting largest volume increases
AP - Tue Feb 18, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Can the Rally in NCI (NCIT) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 18, 6:30AM CST
Can the Rally in NCI (NCIT) Shares Continue?
NCI Has Returned 48.6% Since SmarTrend Recommendation (NCIT)
Comtex SmarTrend(R) - Thu Feb 13, 4:42PM CST
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 3 months, NCI has returned 48.58% as of today's recent price of $8.64.
NCI Reports Fourth Quarter and Fiscal Year 2013 Financial and Operating Results
Business Wire - Wed Feb 12, 3:01PM CST
--EPS of $0.16 exceeds high end of guidance by $0.05;
NCI Awarded $9 Million Contract for the Reserve Component Automation Systems (RCAS) Project Directorate, Alexandria, VA
Business Wire - Mon Feb 10, 7:00AM CST
NCI, Inc. (NASDAQ:NCIT), a leading provider of information technology (IT) and professional services and solutions to U.S. Federal Government agencies, announced today that it was awarded a $9 million contract in support of the Program Executive Office Enterprise Information Systems (PEO EIS) Project Director Reserve Component Automation Systems (RCAS), whose mission includes sustainment of automated information systems that enhance the Army Reserve Component's ability to achieve and sustain critical automation interoperability. The contract will also help to accomplish the directorate's goals of providing the citizen soldiers of our nation with information technology solutions that support unit mobilization planning, training, day-to-day operations, communications, and administration through the use of RCAS. This contract award represents new work for NCI and consists of a three month base period and two additional one-year option periods through 2016.
Shares of NCIT Up 15.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 06, 11:10AM CST
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 3 months, NCI has returned 15.22% as of today's recent price of $6.70.
NCI Shares Up 25.0% Since SmarTrend's Buy Recommendation (NCIT)
Comtex SmarTrend(R) - Thu Jan 23, 9:19AM CST
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 3 months, NCI has returned 25.02% as of today's recent price of $7.27.
NCI, Inc. Schedules Fourth Quarter and Fiscal Year 2013 Conference Call for February 12, 2014
Business Wire - Tue Jan 21, 7:00AM CST
NCI, Inc. (NASDAQ:NCIT) announced today it will issue fourth quarter and fiscal year 2013 financial results after the market closes on Wednesday, February 12, 2014. Management will then discuss the results as well as operating trends and future performance expectations on a conference call beginning at 4:30 p.m. Eastern Time.
NCI Up 21.1% Since SmarTrend Uptrend Call (NCIT)
Comtex SmarTrend(R) - Wed Jan 15, 5:04PM CST
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 2 months, NCI has returned 21.07% as of today's recent price of $7.04.
